HEALTH OF WOMAN. 2016.2(108):90–94; doi 10.15574/HW.2016.108.90 

Diagnostic determinants of placenta conditions for pregnant with obesity and metabolic syndrome

Dyndar E. A., Nykoniuk T. R. 
A.A. Bogomolets National Medical University, Kiev 
 

238 pregnant were examined by the factors of angiogenesis and the placenta condition in order to predict perinatal complications of women with obesity and metabolic syndrome.

Key words: pregnancy, obesity, metabolic syndrome, angiogenesis.

REFERENCES

1. Kuzin AI. 2011. Metabolic's cousins a syndrome: clinical and популяционные aspects . JU.A.Lengin.-Cheljabinsk: Publishing house «Joint-Stock Company» the Chelyabinsk interdistrict printing house»:120.

2. Zadionchenko VS. 2009. A metabolic syndrome: therapeutic possibilities. Consillium Medicum 7;9:725-33.

3. Lipatov IS, Melnikov VА, Tezikov JUV. 2008. Estimation of severity level of placentary insufficiency at pregnant women. Russian bulletin of the obstetric-gynecologist: 8;5:38-43.

4. Filippov OS, Kazantsev AA. 2003. Forecasting the importance of various methods of diagnostics fetoplacental insufficiency. Reproduction Problems 3:44-49.

5. Milovanov AP. 2005. Pathologe of system mother-placenta-fetus: 2005:230.

6. Tischer E, Mitchell R, Hartman T. 2011. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. The Journal of Biological Chemistry 266;18:11947–54.

7. Muller Y.A; Li B; Christinger H.W., 2012. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proceedings of the National Academy of Sciences of the United States of America 94:14:7192–7. http://dx.doi.org/10.1073/pnas.94.14.7192

8. Andraweera PH, Dekker GA, Roberts CT. 2012. The vascular endothelial growth factor family in adverse pregnancy outcomes. Human Reproduction Update 18:4:436–457. http://dx.doi.org/10.1093/humupd/dms011; PMid:22495259

9. Ferrara N, Gerber HP. 2012. The role of vascular endothelial growth factor in angiogenesis. Acta Haematol. 106:4:148–56. http://dx.doi.org/10.1159/000046610

10. Eremina V, Quaggin SE. 2014. The role of VEGF-A in glomerular development and function. Curr. Opin. Nephrol. Hypertens. 13:1:9–15. http://dx.doi.org/10.1097/00041552-200401000-00002

11. Ribatti D. 2012. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br. J. Haematol. 128:3:303–9. http://dx.doi.org/10.1111/j.1365-2141.2004.05291.x; PMid:15667531

12. Tong JP, Yao YF. 2014. Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin. Biochem. 39:3:267–74. http://dx.doi.org/10.1016/j.clinbiochem.2005.11.013; PMid:16409998

13. Matsumoto T, Mugishima H. 2011. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J. Atheroscler. Thromb. 13:3:130–5. http://dx.doi.org/10.5551/jat.13.130